Preoperative glucose-to-lymphocyte ratio predicts survival in cancer

ConclusionElevated preoperative GLR was remarkably associated with a poorer prognosis in patients with NSCLC, CRC, breast cancer, gastric cancer, kidney cancer, liver cancer, esophageal cancer, and melanoma. Preoperative GLR promises to be an essential predictor of survival for cancer patients.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research